		Clinical Features	Time to Death		AGE		GENDER		HISTOLOGICAL.TYPE		PATHOLOGY.T		PATHOLOGY.N		PATHOLOGICSPREAD(M)		TUMOR.STAGE	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q
APC	57 (83%)	12	0.58752	1	0.89685	1	1	1	0.63353	1	0.075339	1	0.81338	1	0.36178	1	0.049096	1
KRAS	38 (55%)	31	0.027947	1	0.53373	1	0.32899	1	0.26979	1	0.097278	1	0.83208	1	0.32689	1	0.309	1
TP53	45 (65%)	24	0.92413	1	0.97605	1	0.80343	1	0.23763	1	0.049758	1	0.93487	1	0.72988	1	0.29747	1
SMAD4	8 (12%)	61	0.44664	1	0.66801	1	1	1	0.0058118	0.732	1	1	0.64542	1	0.3268	1	0.59404	1
KIAA1804	9 (13%)	60	0.44664	1	0.24002	1	1	1	1	1	0.70698	1	1	1	1	1	0.95655	1
FBXW7	9 (13%)	60	0.49722	1	0.91953	1	0.72158	1	1	1	0.5794	1	0.19892	1	0.33783	1	0.34105	1
NRAS	5 (7%)	64	0.11562	1	0.022061	1	1	1	1	1	0.052069	1	0.53001	1	0.55453	1	0.88728	1
TCF7L2	7 (10%)	62	0.66547	1	0.74386	1	1	1	1	1	0.7938	1	0.85011	1	0.26617	1	0.51436	1
PIK3CA	7 (10%)	62	0.49722	1	0.43151	1	1	1	0.034846	1	1	1	0.61951	1	0.58237	1	0.62981	1
OPCML	6 (9%)	63	0.49722	1	0.96607	1	0.69048	1	1	1	0.14793	1	1	1	1	1	0.50363	1
SMAD2	5 (7%)	64	0.49722	1	0.83445	1	1	1	1	1	0.52458	1	0.34235	1	1	1	0.53573	1
SPATA8	3 (4%)	66	NA	NA	0.19432	1	0.07749	1	1	1	1	1	1	1	1	1	0.73698	1
ERBB2	4 (6%)	65	NA	NA	0.27285	1	0.12684	1	1	1	0.4162	1	0.45336	1	1	1	0.66183	1
IL1RAPL2	5 (7%)	64	0.76509	1	0.6385	1	1	1	0.1105	1	1	1	0.81552	1	1	1	0.85239	1
FAM123B	6 (9%)	63	0.48367	1	0.48494	1	0.69048	1	1	1	0.046319	1	1	1	0.20651	1	0.085146	1
ZIM3	5 (7%)	64	0.068954	1	0.23502	1	1	1	0.49308	1	0.36588	1	0.53001	1	1	1	0.66601	1
